Mark N Belkin1, Gaurav A Upadhyay2. 1. Center for Arrhythmia Care, Section of Cardiology, The University of Chicago Medicine, 5841 S. Maryland Avenue, MC 9024, Chicago, IL, 60637, USA. 2. Center for Arrhythmia Care, Section of Cardiology, The University of Chicago Medicine, 5841 S. Maryland Avenue, MC 9024, Chicago, IL, 60637, USA. gupadhyay@medicine.bsd.uchicago.edu.
Abstract
PURPOSE OF REVIEW: We sought to assess the utility of CRT in patients with non-LBBB. RECENT FINDINGS: CRT has an established role as a device-based therapy for patients with HF with systolic dysfunction and intraventricular conduction disease, specifically LBBB. In modern practice, the use of CRT in non-LBBB patients remains controversial, with high rates of non-response for CRT in patients with RBBB, in particular. Recent studies have identified sub-populations of non-LBBB patients that respond to resynchronization, such as those with prolonged PR intervals (≥ 230 ms), with RBBB and concomitant left-sided delay and those with significant burden of right ventricular pacing. As technology has advanced to allow for detailed mapping of LV electrical and mechanical function, benefits have been found with placement of LV leads utilizing intra-procedural mapping to target areas of greatest electrical activation delay or mechanical dyssynchrony, leading to more widespread benefit through the more specific application of CRT.
PURPOSE OF REVIEW: We sought to assess the utility of CRT in patients with non-LBBB. RECENT FINDINGS:CRT has an established role as a device-based therapy for patients with HF with systolic dysfunction and intraventricular conduction disease, specifically LBBB. In modern practice, the use of CRT in non-LBBB patients remains controversial, with high rates of non-response for CRT in patients with RBBB, in particular. Recent studies have identified sub-populations of non-LBBB patients that respond to resynchronization, such as those with prolonged PR intervals (≥ 230 ms), with RBBB and concomitant left-sided delay and those with significant burden of right ventricular pacing. As technology has advanced to allow for detailed mapping of LV electrical and mechanical function, benefits have been found with placement of LV leads utilizing intra-procedural mapping to target areas of greatest electrical activation delay or mechanical dyssynchrony, leading to more widespread benefit through the more specific application of CRT.
Authors: Jagdesh Kandala; Gaurav A Upadhyay; Robert K Altman; Kimberly A Parks; Mary Orencole; Theofanie Mela; E Kevin Heist; Jagmeet P Singh Journal: Eur Heart J Date: 2013-04-09 Impact factor: 29.983
Authors: Michael R Gold; Christophe Thébault; Cecilia Linde; William T Abraham; Bart Gerritse; Stefano Ghio; Martin St John Sutton; Jean-Claude Daubert Journal: Circulation Date: 2012-07-10 Impact factor: 29.690
Authors: Anita Wokhlu; Robert F Rea; Samuel J Asirvatham; Tracy Webster; Kelly Brooke; David O Hodge; Heather J Wiste; Yingxue Dong; David L Hayes; Yong-Mei Cha Journal: Heart Rhythm Date: 2009-07-10 Impact factor: 6.343
Authors: Sylvain Ploux; Joost Lumens; Zachary Whinnett; Michel Montaudon; Maria Strom; Charu Ramanathan; Nicolas Derval; Adlane Zemmoura; Arnaud Denis; Maxime De Guillebon; Ashok Shah; Mélèze Hocini; Pierre Jaïs; Philippe Ritter; Michel Haïssaguerre; Bruce L Wilkoff; Pierre Bordachar Journal: J Am Coll Cardiol Date: 2013-04-16 Impact factor: 24.094
Authors: Gaurav A Upadhyay; Michael Henry; Davide Genovese; Parth Desai; Jonathan Lattell; Hannah Wey; Stephanie A Besser; Zaid Aziz; Andrew D Beaser; Cevher Ozcan; Hemal M Nayak; Roberto M Lang; Roderick Tung Journal: Heart Rhythm O2 Date: 2021-07-26
Authors: Yanrong Yin; Konstantinos Dimopoulos; Eriko Shimada; Karen Lascelles; Samuel Griffiths; Tom Wong; Michael A Gatzoulis; Sonya V Babu-Narayan; Wei Li Journal: J Am Heart Assoc Date: 2019-10-28 Impact factor: 5.501